ROCKWELL MEDICAL, INC. RMTI
Nasdaq · XNAS · stock · Pharmaceutical Preparations
Chart by TradingView
2/9
Piotroski F — financial health
-18.33
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $69.3M | -$5.3M | $11.7M | — | $37.0M |
| 2024 | $101.5M | -$480,000 | $17.5M | — | $32.6M |
| 2023 | $83.6M | -$8.4M | $8.7M | — | $21.3M |
| 2022 | $72.8M | -$18.7M | $4.1M | — | $14.1M |
| 2021 | $61.9M | -$32.7M | -$2.4M | — | $2.5M |
| 2020 | $62.2M | -$30.9M | $2.7M | — | $34.2M |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Hunter Heather | Chief Operating Officer | 2026-03-14 | Tax withheld | 2,444 | $0.90 |
| TIMMINS MEGAN C. | See Remarks | 2026-03-14 | Tax withheld | 3,667 | $0.90 |
| Neri Jesse | SVP and CFO | 2026-03-14 | Tax withheld | 2,444 | $0.90 |
| Chole Timothy | SVP and CCO | 2026-03-14 | Tax withheld | 2,444 | $0.90 |
| Strobeck Mark | President and CEO | 2026-03-14 | Tax withheld | 7,333 | $0.90 |
| Hunter Heather | Chief Operating Officer | 2026-01-02 | Sell | 2,868 | $0.84 |
| Neri Jesse | SVP and CFO | 2026-01-02 | Sell | 886 | $0.84 |
| COOPER JOHN G | director | 2025-11-18 | Sell | 5,079 | $0.87 |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -18.33 (distress)
- Working capital / assets 0.5
- Retained earnings / assets -7.052
- EBIT / assets -0.082
- Equity / liabilities 1.834
Source: SEC EDGAR filings · CIK 0001041024 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.